4.4 Article

Antimicrobial Activity of Molluscan Hemocyanins from Helix and Rapana Snails

期刊

CURRENT PHARMACEUTICAL BIOTECHNOLOGY
卷 17, 期 3, 页码 263-270

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389201016666150907113435

关键词

Antibacterial activity; hemocyanins; Helix aspersa (HaH); Rapana venosa (RvH); Staphylococcus aureus; Streptococcus epidermidis; Streptococcus pyogenes; Escherichia coli

资金

  1. Deutsche Forschungsgemeinstchaft, Germany [DFG-STE 1819/5-1/2012]
  2. Bulgarian Ministry of Education [TK01-496/2009, HTC/01/6]
  3. European Social Fund and Operational Programme Human Resources Development [DMU 03/26, BG051PO001-3.3.06-0025]
  4. Bulgarian Ministry of Education, Youth and Science
  5. Flemish Fund for Scientific Research FWO [VS. 025.12N]
  6. Bulgarian Academy of Sciences BAS
  7. Eberhard-Karls-Universitat, Hautklinik, Sektion Dermatologische Onkologie, Tubingen

向作者/读者索取更多资源

For the first time the antimicrobial activities of hemocyanins from the molluscs Rapana venosa (RvH) and Helix aspersa (HaH) have been tested. From the hemolymph of the garden snail H. aspersa one structural subunit (beta c-HaH) and eight functional units (FUs, beta c-HaH-a to beta c-HaH-h) were isolated, and their N-terminal sequences and molecular weights, ranging between 45 and 65 kDa, determined. The antimicrobial test of the hemocyanins against different bacteria showed that only two FUs from Rapana, RvH1-b and RvH1-e, exhibit a low inhibition effect against Staphylococcus aureus. In contrast and surprisingly, the structural subunit beta c-HaH of H. aspersa not only shows strong antimicrobial activities against S. aureus and the likewise Gram-positive Streptococcus epidermidis, but also against the Gram-negative bacterium Escherichia coli. We suggest that this subunit therefore has the potential to become a substitute for the commonly used antibiotics against which bacterial resistance has gradually been developed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据